Nintedanib plus best supportive care (BSC) versus placebo plus BSC for the treatment of patients (pts) with colorectal cancer (CRC) refractory to standard therapies: Results of the phase III LUME-colon 1 study

被引：2

作者：

Van Cutsem, E. ^{[1
]}

Yoshino, T. ^{[2
]}

Lenz, H-J. ^{[3
]}

Lonardi, S. ^{[4
]}

Falcone, A. ^{[5
]}

Limon, M. L. ^{[6
]}

Saunders, M. P. ^{[7
]}

Sobrero, A. ^{[8
]}

Maiello, E. ^{[9
]}

Park, Y. S. ^{[10
]}

Ferreiro Monteagudo, R. ^{[11
]}

Hong, Y. S. ^{[12
]}

Tomasek, J. ^{[13
]}

Taniguchi, H. ^{[14
]}

Ciardiello, F. ^{[15
]}

Hocke, J. ^{[16
]}

Oum'hamed, Z. ^{[17
]}

Vlassak, S. ^{[18
]}

Studeny, M. ^{[19
]}

Tabernero, J. ^{[20
]}

机构：

[1] Univ Hosp Leuven, Digest Oncol, Campus Gasthuisberg, Leuven, Belgium

[2] Natl Canc Ctr Hosp East, Dept GI Oncol, Kashiwa, Chiba, Japan

[3] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Med Oncol, Los Angeles, CA USA

[4] Ist Oncol Veneto IRCCS, Oncol Med 1, Padua, Italy

[5] Azienda Osped Univ S Chiara, Oncol Med, Pisa, Italy

[6] Hosp Univ Virgen del Rocio, Med Oncol, Seville, Spain

[7] Christie NHS Fdn Trust, Clin Oncol, Manchester, Lancs, England

[8] Osped San Martino Genova, Dept Med Oncol, Genoa, Italy

[9] Osped Casa Sollievo Sofferenza, Oncohematol, San Giovanni Rotondo, Italy

[10] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Med, Seoul, South Korea

[11] Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain

[12] Univ Ulsan, Coll Med, Asan Med Ctr, Oncol, Seoul, South Korea

[13] InVentiv Hlth, Med Commun, London, England

[14] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[15] AOU SUN, Med Oncol, Naples, Italy

[16] Boehringer Ingelheim Pharma GmbH & Co KG, Stat, Tubingen, Germany

[17] Boehringer Ingelheim BV France SAS, Clin Trials, Reims, France

[18] SCS Boehringer Ingelheim Comm V, Med Affairs, Brussels, Belgium

[19] Boehringer Ingelheim GmbH & Co KG, Div Med, Clin Dev Dept, Vienna, Austria

[20] Vall dHebron Univ Hosp, Inst Oncol, Oncol Med, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw435.12

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA20_PR

引用

页数：1

共 50 条

[31] PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
Paz-Ares, Luis
De Marinis, Filippo
Dediu, Mircea
Thomas, Michael
Pujol, Jean-Louis
Bidoli, Paolo
Molinier, Oliver
Sahoo, Tarini Prasad
Laack, Eckart
Reck, Martin
Jaime, Jesus Corral
Melemed, Symantha
John, William J.
Chouaki, Nadia
Zimmermann, Annamaria
Visseren-Grul, Carla
Gridelli, Cesare
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[32] THE COST EFFECTIVENESS OF CETUXIMAB PLUS BEST SUPPORTIVE CARE (BSC) VERSUS BSC ALONE IN LAST LINE FOR KRAS WILD TYPE METASTATIC COLORECTAL CANCER PATIENT POPULATION
Chaugule, S.
Hay, J.
VALUE IN HEALTH, 2012, 15 (04) : A219 - A219
[33] Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)
Laack, E.
Reck, M.
Schumann, C.
Eschbach, C.
Kimmich, M.
Brandts, C.
Paz-Ares, L. G.
De Marinis, F.
Dediu, M.
Pujol, J.-L.
Bidoli, P.
Molinier, O.
Sahoo, T. P.
Corral, J.
Melemed, S. A.
John, W. J.
Chouaki, N.
Zimmermann, A. H.
Visseren-Grul, C. M.
Leschinger, M., I
Thomas, M.
ONKOLOGIE, 2012, 35 : 36 - 37
[34] Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy.
Ciuleanu, T.
Samarzjia, M.
Demidchik, Y.
Beliakouski, V.
Rancic, M.
Bentsion, D. L.
Orlov, S. V.
Schaeffier, B. A.
De Jager, R. L.
Breitz, H. B.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[35] Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
Abou-Alfa, Ghassan K.
Qin, Shukui
Ryoo, Baek-Yeol
Lu, Sheng-Nan
Yen, Chia-Jui
Feng, Yin-Hsun
Lim, Ho Yeong
Izzo, Francesco
Colombo, Massimo
Sarker, Debashis
Bolondi, Luigi
Vaccaro, Gina M.
Harris, William Proctor
Chen, Zhendong
Hubner, Richard
Meyer, Tim
Bomalaski, John S.
Lin, ChenChun
Chao, Yee
Chen, Li-Tzong
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[36] A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer
Wang, J.
Zhao, Z.
Barber, B.
Sherrill, B.
Peeters, M.
Wiezorek, J.
BRITISH JOURNAL OF CANCER, 2011, 104 (12) : 1848 - 1853
[37] A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer
J Wang
Z Zhao
B Barber
B Sherrill
M Peeters
J Wiezorek
British Journal of Cancer, 2011, 104 : 1848 - 1853
[38] A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCER
Wang, J.
Zhao, Z.
Sherrill, B.
Peeters, M.
Wiezorek, J.
Barber, B.
VALUE IN HEALTH, 2011, 14 (03) : A170 - A170
[39] ISEL: a Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small-cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens
Thatcher, N
Chang, A
Parikh, P
Pemberton, K
Archer, V
LUNG CANCER, 2005, 49 : S4 - S4
[40] SAFETY, RESOURCE USE, AND QUALITY OF LIFE (QOL) RESULTS FROM PARAMOUNT: A PHASE III STUDY OF MAINTENANCE PEMETREXED PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEMETREXED-CISPLATIN FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
Gridelli, Cesare
De Marinis, Filippo
Pujol, Jean-Louis
Reck, Martin
Ramlau, Rodryg
Parente, Barbara
Pieters, Thierry
Middleton, Gary
Winfree, Katherine
Melemed, Symantha
Zimmermann, Annamaria H.
John, William
Beyrer, Julie
Chouaki, Nadia
Visseren-Grul, Carla
Paz Ares, Luis
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S323 - S324

← 1 2 3 4 5 →